AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 294: R1185-R1196, 2008. First published February 6, 2008; doi:10.1152/ajpregu.00839.2007
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Corrected Figures
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
294/4/R1185    most recent
00839.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stratigopoulos, G.
Right arrow Articles by Leibel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stratigopoulos, G.
Right arrow Articles by Leibel, R. L.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Regulation of Fto/Ftm gene expression in mice and humans

George Stratigopoulos,1 Stephanie L. Padilla,1 Charles A. LeDuc,1 Elizabeth Watson,1 Andrew T. Hattersley,4 Mark I. McCarthy,2,3 Lori M. Zeltser,1 Wendy K. Chung,1 and Rudolph L. Leibel1

1Division of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University, New York, New York; 2Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, UK; 3Wellcome Trust Centre for Human Genetics, University of Oxford, UK; and 4Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, UK

Submitted 20 November 2007 ; accepted in final form 31 January 2008

Two recent, large whole-genome association studies (GWAS) in European populations have associated a ~47-kb region that contains part of the FTO gene with high body mass index (BMI). The functions of FTO and adjacent FTM in human biology are not clear. We examined expression of these genes in organs of mice segregating for monogenic obesity mutations, exposed to underfeeding/overfeeding, and to 4°C. Fto/Ftm expression was reduced in mesenteric adipose tissue of mice segregating for the Ay, Lepob, Leprdb, Cpefat, or tub mutations, and there was a similar trend in other tissues. These effects were not due to adiposity per se. Hypothalamic Fto and Ftm expression were decreased by fasting in lean and obese animals and by cold exposure in lean mice. The fact that responses of Fto and Ftm expression to these manipulations were almost indistinguishable suggested that the genes might be coregulated. The putative overlapping regulatory region contains at least two canonical CUTL1 binding sites. One of these nominal CUTL1 sites includes rs8050136, a SNP associated with high body mass. The A allele of rs8050136 associated with lower body mass than the C allele preferentially bound CUTL1 in human fibroblast DNA. 70% knockdown of CUTL1 expression in human fibroblasts decreased FTO and FTM expression by 90 and 65%, respectively. Animals and humans with various genetic interruptions of FTO or FTM have phenotypes reminiscent of aspects of the Bardet-Biedl obesity syndrome, a confirmed "ciliopathy." FTM has recently been shown to be a ciliary basal body protein.

obesity; hypothalamus; adipose tissue; CUTL1


Address for reprint requests and other correspondence: R. L. Leibel, 1150 St. Nicholas Ave., Naomi Berrie Diabetes Center, Russ Berrie Medical Science Pavilion, Room 620, New York, NY 10032 (e-mail: rl232{at}columbia.edu)




This article has been cited by other articles:


Home page
 HypertensionHome page
N. J. Timpson, R. Harbord, G. Davey Smith, J. Zacho, A. Tybjaerg-Hansen, and B. G. Nordestgaard
Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?: Mendelian Randomization Using the FTO/MC4R Genotype
Hypertension, July 1, 2009; 54(1): 84 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc GenetHome page
A. S.F. Doney, J. Dannfald, C. H. Kimber, L. A. Donnelly, E. Pearson, A. D. Morris, and C. N.A. Palmer
The FTO Gene Is Associated With an Atherogenic Lipid Profile and Myocardial Infarction in Patients With Type 2 Diabetes: A Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) Study
Circ Cardiovasc Genet, June 1, 2009; 2(3): 255 - 259.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. E. Cecil, R. Tavendale, P. Watt, M. M. Hetherington, and C. N.A. Palmer
An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children
N. Engl. J. Med., December 11, 2008; 359(24): 2558 - 2566.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. L. Leibel
Energy In, Energy Out, and the Effects of Obesity-Related Genes
N. Engl. J. Med., December 11, 2008; 359(24): 2603 - 2604.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
N. J Timpson, P. M Emmett, T. M Frayling, I. Rogers, A. T Hattersley, M. I McCarthy, and G. Davey Smith
The fat mass-and obesity-associated locus and dietary intake in children
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 971 - 978.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.